June 1, 2000-- Technical Chemicals and Products, Inc. (Nasdaq:TCPI - news), a manufacturer and worldwide marketer of point-of-care medical diagnostic products, today announced that the Company's wholly-owned subsidiary, TCPI Holdings, Inc., has signed a purchase agreement to acquire the worldwide over-the-counter (OTC) pregnancy and ovulation self testing business assets of Roche Diagnostics GmbH, including trademarks and distribution rights related to these products.
Technical Chemicals and Products, Inc. is in the final stages of completing a transition toward becoming an integrated designer, developer, manufacturer and global marketer of a wide range of point-of-care medical diagnostic products for use at home, in physician offices and other healthcare locations, which are distributed through domestic and international channels. In addition, the Company's Pharmetrix Division is also involved in the research, development and commercialization of transdermal and dermal drug delivery technologies and skin permeation enhancers. TCPI also manufactures high purity specialty biochemicals.
TCPI was formerly a developmental company that manufactured and sold a narrow range of medical diagnostic products and specialty chemicals on an Original Equipment Manufacture basis. Foremost in TCPI's product portfolio are its non-invasive TD Glucose Monitoring System for diabetics, and its new Total and HDL (good) cholesterol monitoring products.
Market Capitalization $32.2M
Shares Outstanding 12.0M
Float 5.90M
